Farron urges Government to take action over epilepsy deaths

9 Jun 2008

Local MP Tim Farron has today tabled a Parliamentary Question urging the Government to take action over sudden unexplained death in epilepsy (SUDEP), by establishing a national monitoring and research centre. Epilepsy is the most common serious neurological disease, affecting around 1 in 130 people in England, which is a similar number to those suffering diabetes. Unfortunately, deaths as a direct result of epilepsy are rising, and even with optimal care 30% of people with epilepsy will continue to have seizures, and so will continue to be at risk from unexplainable death.

Commenting, Mr Farron, who is a member of the All Party Parliamentary Group on Epilepsy, said:

"For many people with epilepsy it is a life long disease, but despite its prevalence does not enjoy a lot of media exposure, and so often falls under the radar of both the public and politicians. I hope by raising this issue with the Department of Health we can get them to sit up and take notice if this problem. I intend to campaign as hard as possible to establish a national monitoring centre to conduct research into SUDEP - current treatment service improvements will help, but unless we can monitor and understand this issue we will never find a solution, leaving the third of sufferers who would still have seizures at risk of unexplained death.

"If the Government wishes to make a real difference to the health of epilepsy sufferers, NHS R&D funding should be invested in a national monitoring centre as soon as possible - greater understanding of epilepsy will take us closer to lessening the risk of death, and one day hopefully a cure, which surely is a target any Government should aim for."

This website uses cookies

Please select the types of cookies you want to allow.

These are necessary for the website to function properly.
These help us to understand how our visitors use our website.
These allow us to display content from other websites that track you for advertising purposes.